- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02671396
Effects of Virtual Reality Based Training on Posture Stability in Parkinson's Disease
January 28, 2016 updated by: Yea-Ru Yang, National Yang Ming University
Effects of Virtual Reality Based Training on Posture Stability in Individuals With Parkinson's Disease
The present study is to examine the effects of a virtual reality based balance training using the Kinect sensor on postural stability and functional balance in individuals with Parkinson's disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Hoehn and Yahr stages I through III
- A score of more than or equal to 24 on the mini-mental state examination
- Stable medication usage
- Freedom from any other problems that might affect training
Exclusion Criteria:
- Unstable medical conditions
- Histories of other diseases known to interfere with participation in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Virtual reality based intervention
Virtual reality based balance training
|
Virtual reality based balance training
|
Active Comparator: Conventional intervention
Conventional balance training
|
Conventional balance training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Limits of stability test
Time Frame: Change from Baseline at 8 weeks
|
Change from Baseline at 8 weeks
|
One-leg stance test
Time Frame: Change from Baseline at 8 weeks
|
Change from Baseline at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Berg Balance Scale
Time Frame: Change from Baseline at 8 weeks
|
Change from Baseline at 8 weeks
|
Timed up and go test
Time Frame: Change from Baseline at 8 weeks
|
Change from Baseline at 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2013
Primary Completion (Actual)
August 1, 2014
Study Completion (Actual)
August 1, 2014
Study Registration Dates
First Submitted
January 26, 2016
First Submitted That Met QC Criteria
January 28, 2016
First Posted (Estimate)
February 2, 2016
Study Record Updates
Last Update Posted (Estimate)
February 2, 2016
Last Update Submitted That Met QC Criteria
January 28, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13MMHIS120
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
Universidade Federal de PernambucoCompletedParkinson's Disease.Brazil
-
University Hospital, GrenobleCompletedParkinson's Disease (Disorder)France
-
Neurocrine BiosciencesVoyager TherapeuticsCompletedBrain Diseases | Central Nervous System Diseases | Nervous System Diseases | Parkinson's Disease | Parkinsonian Disorders | Movement Disorders | Neurodegenerative Diseases | Idiopathic Parkinson's Disease | Basal Ganglia DiseaseUnited States
-
Shanghai East HospitalShanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaRecruitingIdiopathic Parkinson's DiseaseChina
-
Beijing Tiantan HospitalRecruitingPD - Parkinson's DiseaseChina
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
Clinical Trials on Virtual reality based intervention
-
Chungnam National UniversityRecruitingBreast Cancer | Cognitive Dysfunction | Virtual RealityKorea, Republic of
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Malignant Thoracic Neoplasm | Malignant Head and Neck Neoplasm | Malignant Breast NeoplasmUnited States
-
The University of Texas at ArlingtonRecruitingDepression | Quality of Life | Physical Activity | Anxiety | Post Traumatic Stress Disorder | Cognitive Function | Sedentary Behavior | Heart Rate VariabilityUnited States
-
University of Illinois at Urbana-ChampaignNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Northwestern... and other collaboratorsNot yet recruitingDepressive Symptoms | End Stage Kidney Disease
-
Mental Health Services in the Capital Region, DenmarkRigshospitalet, Denmark; University of Copenhagen; TrygFonden, DenmarkRecruitingDepression | Psychotic Disorders | Schizophrenia | Cognitive Impairment | Bipolar Disorder | Schizotypal DisorderDenmark
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingOpioid Use Disorder | Substance Use Disorders | Opioid UseUnited States
-
Université Catholique de LouvainCliniques universitaires Saint-Luc- Université Catholique de LouvainRecruitingStroke | Cognitive Impairment | Healthy Subjects | HemiparesisBelgium
-
Kocaeli UniversitySakarya University of Applied SciencesCompletedQuality of Life | Pain | Range of Motion | Virtual RealityTurkey
-
University of Massachusetts, LowellSpaulding Rehabilitation Hospital; Hugo W. Moser Research Institute at Kennedy...Recruiting
-
University of ValenciaUniversitat Jaume I; Universitat Politècnica de València; Hospital Clínica BenidormCompleted